Makhdoomi M, Abolghasemi S, Khane Keshi A.
(2025). The effectiveness of schema-based therapy on cognitive avoidance and symptoms of generalized anxiety disorder. Journal of Psychological Science. 24(154), 187-203.
URL: http://psychologicalscience.ir/article-1-2666-en.html
Tonekabon Branch of Islamic Azad University , sh.abolghasemi@iau.ac
Abstract: (83 Views)
Background: The incidence of generalized anxiety disorder severely damages individuals' psychological, cognitive, communication and social processes and reduces their cognitive avoidance. But does schema-based therapy help decrease cognitive avoidance in people with generalized anxiety disorder?
Aims: Therefore the present study was conducted aiming to investigate the effectiveness of schema-based therapy on cognitive avoidance and symptoms of generalized anxiety disorder.
Methods: The research method was a semi-experimental pretest-posttest design with a 45-day follow-up stage by control group. The study population included all people with generalized anxiety disorder referred to 40 psychological counseling centers in the 18th district of Tehran in 2023 which among those 34 cases were selected through available sampling and they were randomly divided into experimental and control groups. The Experimental group received schema therapy (Young, 2008) sessions for eight 90-minutes sessions. All participants were assessed by the generalized anxiety disorder scale (Spitzer et al, 2006) and cognitive avoidance questionnaire (Sexton & Dugas, 2008). Data were analyzed by SPSS-24 software and MANOVA with repeated measure test.
Results: The results indicated the effectiveness of schema therapy on reducing cognitive avoidance and symptoms of generalized anxiety disorder (p< 0.01) and maintaining its effectiveness in the follow-up stage (p< 0.01).
Conclusion: Based on the findings of the present study, it can be concluded that schema-based therapy utilizes techniques such as Schema validity testing, challenging anxious and catastrophic thoughts, role playing, and exposure and response prevention, and has appropriate clinical efficacy to decrease cognitive avoidance and Symptoms of generalized anxiety.
Type of Study:
Research |
Subject:
Special Received: 2024/10/22 | Accepted: 2025/01/9
Rights and permissions |
 |
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) License. |